Huntsman's activities mirror those of several other leading chemical companies featured in extensive interviews in this week's edition of Chemical Week who say they have shifted their focus from cost reduction to profit optimization with the development of sustainabilty-advantaged products and services. To learn more about trends in this area and in regulatory compliance Chemical Week in association with CSC has surveyed 200 industry executives.
Plenty of tech and innovation news emerged - and continues to emerge - from the recent CPhI Worldwide pharmaceutical ingredients expo which took place in Frankfurt at the end of October. Lanxess's subsidiary Saltigo disclosed that it is investing in high potency active pharmaceutical ingredient (HPAPI) capability in the U.S. A raft of other excipients companies at the show, including Ashland and Cargill also have introduced new products.